Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC (United States) holds 0 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 2 active ingredients, holds 0 active Type IV (excipient) Drug Master Files and is linked to 3 FDA-registered manufacturing sites. 33 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Merck Sharp & Dohme LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/merck-sharp-and-dohme-llc

Overview

Merck Sharp & Dohme LLC is a leading global biopharmaceutical company known for its innovative approach to healthcare. As a subsidiary of Merck & Co., Inc., it operates with a focus on research and development to address unmet medical needs.

Core services & business areas

Pharmaceutical ManufacturingClinical TrialsResearch and DevelopmentRegulatory Affairs

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Merck Sharp & Dohme LLC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Merck Sharp & Dohme LLC holds 0 active (4 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MK-6240Inactive2016-05-04
  • MK -2048A DRUG PRODUCTInactive2014-11-12
  • MK-2048 DRUG SUBSTANCEInactive2014-11-12
  • MK-4176 DRUG SUBSTANCEInactive2014-11-12

Excipient Drug Master Files

Merck Sharp & Dohme LLC holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • POLYVINYL ACETATE-CROTONIC ACID COPOLYMERInactive1996-02-16

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Merck Sharp & Dohme LLC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

33 FDA enforcement records linked to this company.

  • recall — Class II2025-12-31

    Presence of particulate matter: potential presence of metal particulates in the product.

  • recall — Class II2025-12-31

    Presence of particulate matter: potential presence of metal particulates in the product.

  • 4832024-08-23

    Procedures for sterile drug products

  • 4832024-08-23

    Investigations of discrepancies, failures

  • recall — Class II2022-04-13

    Presence of foreign substance: Presence of stainless steel particulates in tablets.

  • recall — Class I2021-11-10

    Presence of Particulate Matter: Identified as Glass Particles

  • 4832021-04-16

    Buildings not maintained in good state of repair

  • 4832021-04-16

    Prepared for each batch, include complete information

  • 4832021-04-16

    Authority lacking to review records, investigate errors

  • 4832021-04-16

    Absence of Written Procedures

  • 4832021-04-16

    Calibration/Inspection/Checking not done

  • 4832021-04-16

    Handling and Storage to Prevent Contamination

  • 4832019-06-28

    Investigations of discrepancies, failures

  • 4832019-06-28

    Penicillin processing area not kept separate

  • 4832018-10-30

    Procedures to be written and followed

  • 4832018-10-30

    Investigations of discrepancies, failures

  • 4832018-10-30

    Procedures for sterile drug products

  • 4832014-09-12

    Instruments, apparatus, et. al. not meeting specs

  • 4832014-09-12

    Suitability of testing methods verified

  • 4832014-09-12

    Incoming lots - conformance to written specs-

  • 4832013-08-20

    Contamination, chemical or physical change, deterioration

  • 4832013-08-20

    Investigations of discrepancies, failures

  • 4832013-08-20

    Procedures to be written and followed

  • 4832013-03-26

    Late submission of 15-day report

  • 4832012-08-24

    Air Supply

  • 4832012-08-24

    Investigations of discrepancies, failures

  • 4832010-12-15

    Failure by applicant to report ADE

  • 4832010-12-15

    Procedures to be written and followed

  • 4832010-08-18

    Late submission of 15-day report

  • 4832009-09-29

    Training , Education , Experience overall

  • 4832009-08-31

    Following/documenting laboratory controls

  • 4832009-08-31

    Investigations of discrepancies, failures

  • 4832009-08-31

    Scientifically sound laboratory controls

For suppliers

Is this Merck Sharp & Dohme LLC?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.